{"id":342121,"date":"2026-11-06T15:28:44","date_gmt":"2026-11-06T09:58:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/titan-bio-tech-q2-results-fy27-pat-13-crore\/"},"modified":"2026-11-06T15:28:44","modified_gmt":"2026-11-06T09:58:44","slug":"titan-bio-tech-q2-results-fy27-pat-13-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/titan-bio-tech-q2-results-fy27-pat-13-crore\/","title":{"rendered":"Titan Bio-Tech Q2 Results FY27: Revenue Up 40.65% to Rs 76.46 Cr, PAT Rs 12.55 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Titan Bio-Tech Q2 Results FY27 were declared on 5 November 2026, and the quarterly results show revenue of Rs 76.46 Cr, up 40.65% YoY from Rs 54.36 Cr. Net profit rose 61.52% to Rs 12.55 Cr from Rs 7.77 Cr a year earlier, so strong YoY growth in both lines shaped the quarter. These figures cover the July to September 2026 quarter.<\/p>\n<\/div>\n

Titan Bio-Tech Ltd<\/a> (TITANBIO) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. The results date of 5 November 2026 brings revenue of Rs 76.46 Cr and PAT of Rs 12.55 Cr. Titan Bio-Tech Q2 Results FY27 therefore pair a 40.65% rise in revenue with a 61.52% rise in net profit.<\/p>\n

This Univest results analysis of Titan Bio-Tech Q2 Results covers the financial highlights, business drivers, outlook and risks for the quarter. The Financial Highlights table that follows sets the figures side by side before the narrative turns to what stands out. It also explains how the quarterly results sit beside the return on equity reported for FY26.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n